Text Size

A A A

Search


 

Home | Clinical Trials

FDA Approved Drugs » 1996
Medical Areas: Musculoskeletal | Neurology | Oncology | Family Medicine

View By:Year | Company | Conditions | Therapeutic Areas | Drug Names

Kadian

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Purepac Pharmaceutical
Approval Status: Approved July 1996
Treatment Area: chronic pain

General Information

Kadian, a single daily dosage sustained-release morphine product, has been approved by the FDA. Kadian provides relief for chronic moderate to severe pain (pain related to cancer), and has been demonstrated to be as effective when taken once a day as conventional morphine products taken every four hours.


 Back to Top | Printer Friendly Version

Get Involved

Stroke and You

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org